Virtual screening assisted discovery of novel natural products to inhibit the catalytic mechanism of Mycobacterium tuberculosis InhA

M Jayaraman, L Loganathan, K Muthusamy… - Journal of Molecular …, 2021 - Elsevier
The pandemic prevalence of tuberculosis (TB) caused by increasing drug-resistant
Mycobacterium tuberculosis (Mtb) strains has posed severe global health threats. The …

Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: a molecular docking and molecular dynamics …

SK Miryala, S Basu, A Naha, R Debroy… - Journal of Molecular …, 2021 - Elsevier
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), imposes a
significantly high morbidity threat to humans in both developed and developing nations. The …

Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis

S Sundararajan, K Karunakaran… - Journal of Biomolecular …, 2023 - Taylor & Francis
The highly flexible nature of Mycobacterium tuberculosis (Mtb) can be owed to its tough cell
wall and multiple gene interaction system which makes it resistant to frontline TB drugs …

Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study

M Shahbaaz, A Nkaule, A Christoffels - Scientific reports, 2019 - nature.com
Rv2984 is one of the polyphosphate kinases present in Mycobacterium tuberculosis
involved in the catalytic synthesis of inorganic polyphosphate, which plays an essential role …

In silico analysis to identify potential antitubercular molecules in Morus alba through virtual screening and molecular dynamics simulations

M Khan, S Khan, FL Alshammary, S Zaidi… - Journal of …, 2024 - Taylor & Francis
A major obstacle in the treatment of tuberculosis (TB) is to combat the emerging resistant
strains of its causing agent ie Mycobacterium tuberculosis (MTb). The emergence of …

Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach

A Sharma, MH Islam, N Fatima, TK Upadhyay… - Molecular biology …, 2019 - Springer
Tuberculosis (TB) is a leading cause of mortality amongst infectious diseases. While the anti-
TB drugs can cure TB, the non-compliance and rapidly increasing resistance is of serious …

Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against α-tryptophan …

S Naz, U Farooq, S Khan, R Sarwar… - Journal of …, 2021 - Taylor & Francis
Discovery of new anti-tuberculosis drugs with novel mode of action is urgently needed. The
tryptophan synthase is a genetically validated enzyme that catalyzes last step of tryptophan …

Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti …

S Naz, U Farooq, S Ali, R Sarwar, S Khan… - Journal of …, 2019 - Taylor & Francis
Multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis has emerged as
global health threat, causing millions of deaths worldwide. Identification of new drug …

In silico studies of alkaloids and their derivatives against N-acetyltransferase EIS protein from Mycobacterium tuberculosis

SP Swain, S Ahamad, N Samarth, S Singh… - Journal of …, 2023 - Taylor & Francis
Antibiotic resistance against Mycobacterium tuberculosis (M. tb.) has been a significant
cause of death worldwide. The Enhanced intracellular survival (EIS) protein of the bacteria is …

Binding thermodynamics and dissociation kinetics analysis uncover the key structural motifs of phenoxyphenol derivatives as the direct InhA inhibitors and the hotspot …

Q Zhang, J Han, Y Zhu, S Tan, H Liu - International Journal of Molecular …, 2022 - mdpi.com
Given the current epidemic of multidrug-resistant tuberculosis, there is an urgent need to
develop new drugs to combat drug-resistant tuberculosis. Direct inhibitors of the InhA target …